A patented, generalized drug-response foundation model trained to internalize relationships between chemical structure, tumor biology, and therapeutic response, CertisAI™ enables zero-shot prediction ...

Rising rehospitalization rates among skilled nursing facility (SNF) residents are not just costly — averaging over $15,000 per readmission — they hinder clinicians’ ability to deliver efficient and ...

Heavy metal contamination in soils remains a persistent global challenge, threatening food safety, water quality, and ...

Dana-Farber Cancer Institute investigators have developed an online, easy-to-use tool that more accurately predicts when a ...

Camrelizumab combined with rivoceranib and TACE in the perioperative treatment of hepatocellular carcinoma: A randomized, open-label multicenter trial. This is an ASCO Meeting Abstract from the 2025 ...

Two landmark AI innovations, conversational data intelligence and predictive scenario modeling, establish Decusoft as the ...